QPS Neuropharmacology

QPS Neuropharmacology

Forschungsdienstleistungen

Grambach, Graz 709 Follower:innen

Global Contract Research Organization delivering Custom-Built Neuropharmacology Solutions

Info

QPS Neuropharmacology is a division of QPS that focuses on preclinical studies in CNS diseases, Orphan Diseases and Mental Disorders. Our profound expertise in neuroscience and two decades of experience in contract research results in a sustainable advantage for our customers. The on-site availability of highly predictive disease models and unparalleled experience with studies performed for biopharmaceutical companies of all sizes makes QPS Neuropharmacology the first choice for most CNS drug development needs. QPS Neuropharmacology offers a sophisticated range of validated transgenic and non-transgenic in vivo and in vitro models that guarantee an in depth profiling of your new chemical or biological compounds using both novel and established drug targets that play a role in the complex etiology of neurodegenerative diseases.

Website
http://www.qpsneuro.com
Branche
Forschungsdienstleistungen
Größe
1.001–5.000 Beschäftigte
Hauptsitz
Grambach, Graz
Spezialgebiete
Contract Research Organization (CRO), CNS Research, Neuropharmacology, Clinical Research, Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Lysosomal Storage Diseases, Amyotrophic Lateral Sclerosis, Tauopathies, Transgenic Research Models, CNS Drug Development, Neurodegenerative Disease, In Vitro Research Models, Orphan Diseases, Behavioral Tests, Histology, Biochemical and Molecular Analyses, Treatment and Surgery und Biosafety Level 2

Updates

Verbundene Seiten

Ähnliche Seiten